|
Diabetes, Vol 48, Issue 8 1607-1614, Copyright © 1999 by American Diabetes Association
Metabolic factors contributing to increased resting metabolic rate and decreased insulin-induced thermogenesis during the development of type 2 diabetes
C Weyer, C Bogardus and RE Pratley
Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona 85016, USA. cweyer@phx.niddk.nih.gov
Previous studies have indicated that individuals with type 2 diabetes have
an increased resting metabolic rate (RMR) but decreased insulin-induced
thermogenesis (IIT) compared with those with normal glucose tolerance
(NGT). When and by which mechanisms these abnormalities occur during the
development of diabetes remain unknown. In 560 Pima Indians, sleeping
metabolic rate (respiratory chamber) was higher not only in subjects with
diabetes (+4.9%, P < 0.001) but also in those with impaired glucose
tolerance (IGT) (+2.7%, P < 0.01) compared with subjects with NGT.
Longitudinally, RMR (ventilated hood) increased progressively in 17
subjects in whom glucose tolerance deteriorated from NGT to IGT (+4.2%) to
diabetes (+2.6%) over 5.1 +/- 1.4 years (P < 0.05 for trend). In
parallel, IIT (% increase in metabolic rate during an insulin/glucose
infusion) decreased during the transition from NGT (11.7%) to IGT (7.3%) to
diabetes (6.5%) (P < 0.05 for trend). In 151 subjects, basal endogenous
glucose output (3-3H-glucose), fasting insulin and free fatty acid
concentrations, and glucose disposal (hyperinsulinemic clamp) were
significant determinants of RMR, independent of body composition, age, and
sex. Nonoxidative and oxidative glucose disposal, RMR, and fasting insulin
and glucose concentrations were determinants of IIT. Differences in RMR and
IIT between glucose tolerance groups decreased after adjusting for these
factors. These findings indicate that increases in RMR and decreases in IIT
occur early in the development of type 2 diabetes, and that both changes
are related to the progressive metabolic abnormalities that occur during
the development of the disease.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Raffaitin, C. Lasseur, P. Chauveau, N. Barthe, H. Gin, C. Combe, and V. Rigalleau
Nutritional status in patients with diabetes and chronic kidney disease: a prospective study
Am. J. Clinical Nutrition,
January 1, 2007;
85(1):
96 - 101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Jacobson, T. Rankinen, A. Tremblay, L. Perusse, Y. C Chagnon, and C. Bouchard
Resting metabolic rate and respiratory quotient: results from a genome-wide scan in the Quebec Family Study
Am. J. Clinical Nutrition,
December 1, 2006;
84(6):
1527 - 1533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bosy-Westphal and M. J Muller
Energy intake or energy expenditure?
Am. J. Clinical Nutrition,
October 1, 2006;
84(4):
945 - 945.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Pannacciulli, J. C Bunt, J. Koska, C. Bogardus, and J. Krakoff
Higher fasting plasma concentrations of glucagon-like peptide 1 are associated with higher resting energy expenditure and fat oxidation rates in humans.
Am. J. Clinical Nutrition,
September 1, 2006;
84(3):
556 - 560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Silva
Thermogenic Mechanisms and Their Hormonal Regulation
Physiol Rev,
April 1, 2006;
86(2):
435 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Pannacciulli, J. C. Bunt, E. Ortega, T. Funahashi, A. D. Salbe, C. Bogardus, and J. Krakoff
Lower Total Fasting Plasma Adiponectin Concentrations Are Associated with Higher Metabolic Rates
J. Clin. Endocrinol. Metab.,
April 1, 2006;
91(4):
1600 - 1603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bitz, S. Toubro, T. M. Larsen, H. Harder, K. L. Rennie, S. A. Jebb, and A. Astrup
Increased 24-h Energy Expenditure in Type 2 Diabetes
Diabetes Care,
October 1, 2004;
27(10):
2416 - 2421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Weyer, R. L Walford, I. T Harper, M. Milner, T. MacCallum, P A. Tataranni, and E. Ravussin
Energy metabolism after 2 y of energy restriction: the Biosphere 2 experiment
Am. J. Clinical Nutrition,
October 1, 2000;
72(4):
946 - 953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Weyer, R. E. Pratley, A. D. Salbe, C. Bogardus, E. Ravussin, and P. A. Tataranni
Energy Expenditure, Fat Oxidation, and Body Weight Regulation: A Study of Metabolic Adaptation to Long- Term Weight Change
J. Clin. Endocrinol. Metab.,
March 1, 2000;
85(3):
1087 - 1094.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|